Inspecs Group plc (SPEC) - Net Assets

Latest as of December 2025: GBX79.72 Million GBX ≈ $9.70K USD

Based on the latest financial reports, Inspecs Group plc (SPEC) has net assets worth GBX79.72 Million GBX (≈ $9.70K USD) as of December 2025. Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (GBX202.23 Million ≈ $24.61K USD) and total liabilities (GBX122.51 Million ≈ $14.91K USD). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off. Check SPEC strategic assets to equity ratio to assess the company's strategic physical and investment asset allocation.

Key Net Assets Metrics

Metric Value
Current Net Assets GBX79.72 Million
% of Total Assets 39.42%
Annual Growth Rate 48.81%
5-Year Change -45.11%
10-Year Change N/A
Growth Volatility 257.19

Inspecs Group plc - Net Assets Trend (2016–2025)

This chart illustrates how Inspecs Group plc's net assets have evolved over time, based on quarterly financial data. For live market cap and overall valuation, see Inspecs Group plc stock valuation.

Annual Net Assets for Inspecs Group plc (2016–2025)

The table below shows the annual net assets of Inspecs Group plc from 2016 to 2025. Also explore SPEC net asset momentum to track the company's year-over-year net asset growth rate.

Year Net Assets Change
2025-12-31 GBX79.72 Million
≈ $9.70K		 -19.22%
2024-12-31 GBX98.69 Million
≈ $12.01K		 -4.67%
2023-12-31 GBX103.52 Million
≈ $12.60K		 -20.43%
2022-12-31 GBX130.09 Million
≈ $15.83K		 -10.42%
2021-12-31 GBX145.22 Million
≈ $17.67K		 -0.41%
2020-12-31 GBX145.82 Million
≈ $17.74K		 +365.16%
2019-12-31 GBX31.35 Million
≈ $3.81K		 +38.01%
2018-12-31 GBX22.71 Million
≈ $2.76K		 +16.19%
2017-12-31 GBX19.55 Million
≈ $2.38K		 +777.26%
2016-12-31 GBX2.23 Million
≈ $271.14		 --

Equity Component Analysis

This analysis shows how different components contribute to Inspecs Group plc's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.

Equity Composition Insights

  • Retained earnings have decreased by 1295244100.0% over the analyzed period, potentially due to dividend distributions or operating losses.

Current Equity Component Breakdown (December 2025)

Component Amount Percentage
Common Stock GBX1.02 Million 1.28%
Other Comprehensive Income GBX2.80 Million 3.51%
Other Components GBX89.51 Million 112.28%
Total Equity GBX79.72 Million 100.00%

Inspecs Group plc Competitors by Market Cap

The table below lists competitors of Inspecs Group plc ranked by their market capitalization.

Company Market Cap
Generation Income Properties Inc
NASDAQ:GIPR
 $1.25 Million
Baroyeca Gold & Silver Inc
V:BGS
 $1.25 Million
MFC Industrial Real Estate Investment Trust
BK:MIT
 $1.25 Million
Biomx Inc
NYSE MKT:PHGE
 $1.25 Million
Pacific Imperial Mines Inc
V:PPM
 $1.24 Million
WFM Inc.
KQ:035290
 $1.24 Million
RM Plc
LSE:RM
 $1.24 Million
Xaar plc
LSE:XAR
 $1.24 Million

Equity Growth Attribution

This analysis shows how different factors contributed to changes in Inspecs Group plc's equity between the two most recent reporting periods.

Equity Growth Insights

  • From 2024 to 2025, total equity changed from 98,686,000 to 79,716,000, a change of -18,970,000 (-19.2%).
  • Net loss of 6,510,000 reduced equity.
  • Other comprehensive income increased equity by 2,801,000.
  • Other factors decreased equity by 15,261,000.

Equity Change Factors (2024 to 2025)

Factor Impact Contribution
Net Income GBX-6.51 Million -8.17%
Other Comprehensive Income GBX2.80 Million +3.51%
Other Changes GBX-15.26 Million -19.14%
Total Change GBX- -19.22%

Book Value vs Market Value Analysis

This analysis compares Inspecs Group plc's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.

Valuation Insights

  • Current price-to-book ratio: 119.25x
  • The company is trading at a significant premium to its book value, suggesting the market values its earnings potential, brand, or other intangibles highly.
  • The price-to-book ratio has decreased from 3662.30x to 119.25x over the analyzed period, indicating reduced market premium.

Historical Price-to-Book Ratios

Date Book Value per Share Market Price P/B Ratio
2016-12-31 GBX0.03 GBX93.50 x
2017-12-31 GBX0.28 GBX93.50 x
2018-12-31 GBX0.32 GBX93.50 x
2019-12-31 GBX0.44 GBX93.50 x
2020-12-31 GBX2.11 GBX93.50 x
2021-12-31 GBX1.37 GBX93.50 x
2022-12-31 GBX1.28 GBX93.50 x
2023-12-31 GBX1.02 GBX93.50 x
2024-12-31 GBX0.97 GBX93.50 x
2025-12-31 GBX0.78 GBX93.50 x

Capital Efficiency Dashboard

This dashboard shows how efficiently Inspecs Group plc utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.

Capital Efficiency Insights

  • Current Return on Equity (ROE): -8.17%
  • The company may be facing challenges in efficiently utilizing shareholder equity.
  • DuPont Analysis Breakdown:
  • • Net Profit Margin: -3.40%
  • • Asset Turnover: 0.95x
  • • Equity Multiplier: 2.54x
  • Recent ROE (-8.17%) is below the historical average (2.35%), suggesting potential challenges in capital efficiency.

Historical Capital Efficiency Metrics

Year Return on Equity Net Profit Margin Asset Turnover Equity Multiplier Economic Value Added
2016 31.80% 2.60% 1.54x 7.93x GBX393.76K
2017 -12.65% -5.03% 0.70x 3.57x GBX-4.43 Million
2018 14.63% 6.11% 0.79x 3.05x GBX1.05 Million
2019 15.67% 8.02% 0.86x 2.28x GBX1.78 Million
2020 -4.49% -18.80% 0.11x 2.13x GBX-21.12 Million
2021 -2.77% -2.21% 0.56x 2.25x GBX-18.55 Million
2022 -4.86% -3.14% 0.69x 2.25x GBX-19.33 Million
2023 -0.96% -0.49% 0.92x 2.14x GBX-11.35 Million
2024 -4.67% -2.32% 0.90x 2.23x GBX-14.48 Million
2025 -8.17% -3.40% 0.95x 2.54x GBX-14.48 Million

Industry Comparison

This section compares Inspecs Group plc's net assets metrics with peer companies in the Medical Instruments & Supplies industry.

Industry Context

  • Industry: Medical Instruments & Supplies
  • Average net assets among peers: $567,043,333
  • Average return on equity (ROE) among peers: 15.02%

Peer Company Comparison

Company Net Assets Return on Equity Debt-to-Equity Market Cap
Inspecs Group plc (SPEC) GBX79.72 Million 31.80% 1.54x $1.24 Million
Advanced Medical Solutions Group plc (AMS) $27.80 Million 17.38% 0.19x $7.46 Million
ConvaTec Group PLC (CTEC) $1.67 Billion 6.73% 1.25x $51.04 Million
Tristel (TSTL) $2.63 Million 20.95% 0.78x $2.37 Million

About Inspecs Group plc

LSE:SPEC UK Medical Instruments & Supplies
Market Cap
$1.24 Million
GBX10.21 Billion GBX
Market Cap Rank
#30549 Global
#773 in UK
Share Price
GBX93.50
Change (1 day)
+0.00%
52-Week Range
GBX39.50 - GBX100.50
All Time High
GBX405.33
Categories
Companies in UK Medical Instruments & Supplies
About

INSPECS Group plc designs, produces, sells, markets, and distributes fashion eyewear, lenses, and OEM products in the United Kingdom, Europe, North America, South America, Asia, Africa, and Australia. It operates through Frames and Optics product distribution and Manufacturing segments. The company offers its products under the retail brands, such as Barbour, Barbour International, BUFFALO David … Read more